CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $9.07M invested in Celyad Oncology SA American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
2
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FIG
1
Fortress Investment Group
New York
$8.97M
Morgan Stanley
2
Morgan Stanley
New York
$26K -$1.38K -1,000 -5%
Citadel Advisors
3
Citadel Advisors
Florida
$22K +$22K +16,654 New
Wells Fargo
4
Wells Fargo
California
$18K -$1.4K -1,000 -7%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$16K +$16K +11,602 New
UBS Group
6
UBS Group
Switzerland
$12K +$6.42K +4,658 +115%
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$5K
Osaic Holdings
8
Osaic Holdings
Arizona
$2K
HF
9
HRT Financial
New York
-$57K -33,288 Closed
CS
10
Credit Suisse
Switzerland
-$1K -838 Closed